Effects of Decalcifying Agents of Variable Duration on PD-L1 Immunohistochemistry

PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters

(2018) Manuel A. Silva et al.   PLoS One

Effects of Hydrochloric Acid and Formic Acid Decalcification on Breast Tumor Biomarkers and HER2 Fluorescence In Situ Hybridization

(2017) Beth Z. Clark et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases

(2016) Emanuela Veras et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

(2016) Charlotte Roach et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

CytoLyt® Fixation and Decalcification Pretreatments Alter Antigenicity in Normal Tissues Compared With Standard Formalin Fixation

(2015) Jennette R. Gruchy et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Standardization of Diagnostic Immunohistochemistry: Literature Review and Geisinger Experience

(2014) Fan Lin et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center

(2014) Patrick L. Fitzgibbons et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

(2014) Roy S. Herbst et al.   NATURE

The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor and HER2 expression in invasive breast carcinoma

(2012) Isil Z Yildiz-Aktas et al.   MODERN PATHOLOGY

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE